Bristol-Myers Squibb Co (BMY)
67.24
-0.19 -0.28%
NYSE
Jan 23, 16:59
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 24.17B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 3.47 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 5.655B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 69.87% |
| Profit Margin (Quarterly) | 22.52% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 2.50% |
| Price and Valuation | |
| Market Cap | 157.62B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 4.551 |
| PE Ratio | 19.38 |
| Price to Book Value | 8.932 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 1.414 |
| Free Cash Flow (Quarterly) | 2.366B |
| Return on Equity | Upgrade |
View All BMY News
News
-
WireHeadlineTime (ET)
-
Yahoo01/23 12:45
-
Yahoo01/23 10:39
-
Yahoo01/22 17:45
-
Yahoo01/22 10:03
-
Yahoo01/22 09:28
-
Yahoo01/22 09:16
-
Yahoo01/22 07:04
-
Yahoo01/21 09:22
-
Yahoo01/20 11:50
-
Yahoo01/20 11:40
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 04/24/2020 10:30 EDT | Misc | Bristol-Myers Squibb Co First Quarter Earnings Conference Call in 2020 |
| 04/24/2020 | Earnings | Bristol-Myers Squibb Co First Quarter Earnings in 2020 Release |
| 02/06/2020 08:30 EST | Misc | Bristol-Myers Squibb Co Fourth Quarter Earnings Conference Call for 2019 |
| 02/06/2020 | Earnings | Bristol-Myers Squibb Co Fourth Quarter Earnings in 2019 Release |
| 01/02/2020 | Dividends | Amount: 0.45, Declared Date: Dec 05 2019, Pay Date: Feb 03 2020 |
| 10/31/2019 08:30 EDT | Misc | Bristol-Myers Squibb Co Third Quarter Earnings Conference Call for 2019 |
| 10/31/2019 | Earnings | Bristol-Myers Squibb Co Third Quarter Earnings Results for 2019 |
| 10/03/2019 | Dividends | Amount: 0.41, Declared Date: Sep 11 2019, Pay Date: Nov 01 2019 |
| 07/25/2019 10:30 EDT | Misc | Bristol-Myers Squibb Co Second Quarter Earnings Conference Call in 2019 |
| 07/25/2019 | Earnings | Bristol-Myers Squibb Co Second Quarter Earnings in 2019 Release |
Fundamentals
Income Statement View Statement
Cash Flow Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.bms.com
- Investor Relations URL: N/A
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Large Cap/Blend
- Next Earnings Release: Feb. 06, 2020
- Last Earnings Release: Oct. 31, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Jan. 02, 2020
- Description: Bristol-Myers Squibb discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 67.24 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| VGHCX | Vanguard Health Care Inv | 5.98% |
| SCHD | Schwab US Dividend Equity ETF™ | 4.70% |
| XLV | Health Care Select Sector SPDR® ETF | 4.05% |
| VHCIX | Vanguard Health Care Index Admiral | 3.35% |
| VHT | Vanguard Health Care ETF | 3.35% |
| MOAT | VanEck Vectors Morningstar Wide Moat ETF | 2.78% |
| DODGX | Dodge & Cox Stock | 2.63% |
| OIEFX | JPMorgan Equity Income R2 | 2.13% |
| VHYAX | Vanguard High Dividend Yield Index Adm | 1.39% |
| VYM | Vanguard High Dividend Yield ETF | 1.39% |
| DGRO | iShares Core Dividend Growth ETF | 1.16% |
| VWELX | Vanguard Wellington™ Inv | 0.85% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BMY Tweets Stocktwits
Advertisement
